NFATc1 Regulates PD-1 Expression upon T Cell Activation

Cited by (415)

Items 301–400 of 415

1. A data-driven Boolean model explains memory subsets and evolution in CD8+ T cell exhaustion
   Geena V. Ildefonso, Stacey D. Finley · 2023 · npj Systems Biology and Applications
2. Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome
   Andrés Chang, Danielle Schlafer, Christopher R. Flowers, Pamela B. Allen · 2017 · Expert Opinion on Investigational Drugs
3. Citrullinated peptides as drug candidates for rheumatoid arthritis
   Adrian H. Bustos, Mads Brüner, Tue Wenzel Kragstrup, Kira Astakhova · 2025 · Frontiers in Immunology
4. Treatment of multiple myeloma: What is the impact on T-cell function?
   Chenggong Li, Xindi Wang, Jia Ming Stella Xu, Jiachen Liu, Heng Mei · 2024 · Therapeutic Advances in Hematology
5. Type I Interferon Activates PD-1 Expression through Activation of the STAT1-IRF2 Pathway in Myeloid Cells
   Liyan Liang, Yingcui Yang, Kaidi Deng, Yanmin Wu, Yan Li, Liya Bai, Yinsong Wang, Chunwan Lu · 2024 · Cells
6. Integrating mechanism-based T cell phenotypes into a model of tumor–immune cell interactions
   Neel Tangella, Colin G. Cess, Geena V. Ildefonso, Stacey D. Finley · 2024 · APL Bioengineering
7. Renal Transplantation in HIV-Positive Recipients
   Jayme E. Locke, Dorry Lidor Segev · 2010 · Current Infectious Disease Reports
8. Animal models for viral infection and cell exhaustion
   Colleen S. McGary, Guido Silvestri, Mirko Paiardini · 2014 · Current Opinion in HIV and AIDS
9. Co-inhibitory receptors, transcription factors and tolerance
   Adel Mohammadzadeh · 2020 · International Immunopharmacology
10. NFAT as a Biomarker and Therapeutic Target in Non–Small Cell Lung Cancer–Related Brain Metastasis
    Peng Lü, Yihao Tao, Rui Ting Wu, Jing Su, Maoyuan Sun, Yuan Cheng, Zongyi Xie, Jinning Mao, Xiaohui Zhan, Guodong Liu · 2021 · Frontiers in Oncology
11. Immunoterapia z użyciem przeciwciał monoklonalnych ukierunkowanych na szlak PD-1/PD-L1 w chorobach nowotworowych
    Aneta Malesa, Justyna Nowak, Katarzyna Skórka, Marta Karp, Krzysztof Giannopoulos · 2018 · Acta Haematologica Polonica
12. T‐bet interferes with PD‐1/PD‐L1‐mediated suppression of CD4+ T cell inflammation and survival in Crohn's disease
    Fei Ma, Mingning Zhao, Zhenyu Song, Zhongchuan Wang · 2019 · Clinical and Experimental Pharmacology and Physiology
13. Recent advances on T-cell exhaustion in malaria infection
    Esaki Muthu Shankar, Ramachandran Vignesh, Aditya Prasad Dash · 2018 · Medical Microbiology and Immunology
14. Tacrolimus exposure windows responsible for Listeria monocytogenes infection susceptibility
    Hilary Miller‐Handley, John J. Erickson, Emily J. Gregory, Nina Salinger Prasanphanich, Tzu‐Yu Shao, Sing Sing Way · 2021 · Transplant Infectious Disease
15. Checkpoint blockade accelerates a novel switch from an NKT-driven TNFα response toward a T cell driven IFN-γ response within the tumor microenvironment
    Shota Aoyama, Ryosuke Nakagawa, Satoshi Nemoto, Patricio Perez-Villarroel, James J. Mulé, Adam William Mailloux · 2021 · Journal for ImmunoTherapy of Cancer
16. Role of Cytokines in Liver Fibrosis
    Merve Anapalı, Eda Balkan · 2021 · Kafkas Journal of Medical Sciences
17. PD-1⁺ CD8⁺ T cells: roles of PD-1 beyond an exhaustion marker
    Jingyi Chen, Zixiang Chen, Liangjie Xu, Jieting Jia, Ke Rui, Jie Tian · 2026 · Seminars in Immunopathology
18. Altered microRNA expression profile is linked to T-cell exhaustion-related pathways in pediatric patients with acute lymphoblastic leukemia
    Mona F. Zidan, Abdel‐Aziz A. Zidan, Mohamed Saad, Mohamed Ramadan El-Shanshory, Usama Bakry, Ashraf Sobh, Said Abdou, Mohamed Labib Salem · 2022 · Human Immunology
19. Multifaceted roles of PD‐1 in tumorigenesis: From immune checkpoint to tumor cell‐intrinsic function
    Huiqing Chen, Jiayu Wei, Zhen Zhu, Yongzhong Hou · 2024 · Molecular Carcinogenesis
20. PD-1 receptor on immune cells, its expression and potential role in cancer therapy
    D. S. Elezov, Igor Vladimirovich Kudryavtsev · 2019 · Cellular Therapy and Transplantation
21. Programmed Death 1 ( PD 1)‐Mediated T ‐Cell Apoptosis and Cancer Immunotherapy
    Chandi Charan Mandal, Jatin Mehta, Vijay Kumar Prajapati · 2018 · Wiley eBooks
22. Physical activity attenuates PD-1/PD-L1 expression and enhances CD4⁺ T-cell function in COPD patients
    Enrique Alfaro, Elena Díaz‐García, Sara García-Tovar, Raúl Galera, Raquel Casitas, Elisabet Martínez-Cerón, María Torres-Vargas, José M. Padilla, Cristina López Fernández, Paula Pérez-Moreno et al. · 2025 · Scientific Reports
23. T cells co-expressing high levels of CD29 and CD99 show increased cytotoxic potential and are upregulated in Sjögren’s disease
    Zhonghui Zhang, Ayibaota Bahabayi, Y M Gao, Danni Liu, Ainizati Hasimu, Yangyang Zhang, Siyu Guo, Qi Li, Ziqi Xiong, Ke Zhang et al. · 2026 · The Journal of Immunology
24. Immune Responses to Persistent or Recurrent Antigens: Implications for Immunological Memory and Immunotherapy
    2021 · Frontiers research topics
25. Neoadjuvant PD-1/PD-L1 axis blockade for patients with head and neck squamous cell carcinoma
    Shuang Huang, Chuang Xiong, Kui Tan · 2023 · American Journal of Otolaryngology
26. RACK1 contributes to the upregulation of embryonic genes in a model of cardiac hypertrophy
    Marcello Ceci, Davide Bonvissuto, Flavia Papetti, Federica Silvestri, Claudio Sette, Elisabetta Catalani, Davide Cervia, Rosalba Gornati, Nicla Romano · 2024 · Scientific Reports
27. A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma
    Omar Alhalabi, Mohamed Alaa Gouda, Denái R. Milton, Hassan Ahmed Momin, Bulent Yilmaz, Bettzy Stephen, Chinenye Lynette Ejezie, Justin Tyler Moyers, Serdar A. Gurses, Jeffrey How et al. · 2025 · Cancer Medicine
28. YY1 expression and PD-1 regulation in CD8 T lymphocytes
    Roni Touboul, Benjamin Bonavida · 2021 · Elsevier eBooks
29. The Multifaceted Role of PD-1 in Health and Disease
    Mohamed El Sherif Gadelhaq Badr, Kikumi Hata, Masae Furuhata, Hiroko Toyota, Tadashi Yokosuka · 2016 · Springer eBooks
30. INTRACELLULAR MECHANISMS OF TUMOR CELL IMMUNORESISTANCE
    Justyna Magdalena Hermanowicz, Beata Sieklucka, Krzysztof Nosek, Dariusz Pawlak · 2020 · Acta Biochimica Polonica
31. Programmed cell death 1 positive lymphocytes at palate tonsils in the elder patients with chronic tonsillitis
    Yuki Fujihara, Koji Yamanegi, Yasuyuki Nagasawa, A Yoshida, Yukako Goto, Shunsuke Kumanishi, Hiroyuki Futani, Shigeo Fukunishi, Shinichi Yoshiya, Hiroshi Nishiura · 2021 · Biochemistry and Biophysics Reports
32. Chromatin repression by PRC2 results in reduced gene expression driving key features of CD8 T cell exhaustion
    Parisa Samareh, Paula A. Agudelo-Garcia, Zhen Zhang, Michael B. Gilbert, Mariel R. Mendoza, Hua Huang, Jennifer E. Wu, Amy E. Baxter, Zeyu Chen, Kate Alexander et al. · 2025 · The Journal of Immunology
33. Immune Checkpoint Restoration as a Therapeutic Strategy to Halt Diabetes-Driven Atherosclerosis
    Dwaipayan Saha, Preyangsee Dutta, Abhijit Chakraborty · 2025 · Biology
34. Genetic disruption of Pdcd-1 upstream enhancer boosts T cell function and antitumor responses
    Chandsultana Jerin, Wooseok Seo, Hiroyoshi Nishikawa · 2026 · Immunology Letters
35. Characterization of alternative sPD-1 isoforms reveals that ECD sPD-1 signature predicts an efficient antitumor response
    Ping Hou, Li Hu, Junrong Zhang, Xiaoyan Zhou, Yonglei Xiao, Lijun Li, Qiongwen Wu, Jing Liu, Yuhong Lin, Ling Chen · 2025 · Communications Biology
36. Layers of regulation in induction of mixed chimerism by anti-CD40L
    Carrie L. Lucas, Megan Sykes · 2011 · Chimerism
37. Autoimmune Addison’s Disease: Genetic Aetiology and Pathophysiology
    Agnieszka Pazderska, Simon H. S. Pearce, Anna Louise Mitchell · 2017 · Contemporary Endocrinology
38. Round optimization for improved discovery of native bispecific antibodies
    Franck Gueneau, Ulla Ravn, Nicolas Fischer · 2018 · Methods
39. Mechanisms of resistance to anti-Pd-1 therapy in metastatic cutaneous melanoma
    Ya. А. Zhulikov, Игорь Вячеславович Самойленко, Лев Вадимович Демидов · 2018 · Russian Journal of Biotherapy
40. T-B Collaboration in Autoimmunity, Infection, and Transplantation
    Daniel Francis Ditoro, Naoka Murakami, Shiv S Pillai · 2023 · Transplantation
41. Expression of immune checkpoint molecules in Iraqi acute myeloid leukemia patients
    Hassnien Samer Al-Hashemi, Sabah A. Hameid A. Rahman, ZeyadAhmed Shabeeb · 2021 · Iraqi Journal of Hematology
42. Immune suppression sustained allograft acceptance requires PD1 inhibition of CD8+ T cells
    Hilary Miller‐Handley, Gavin Harper, Giang H. Pham, Lucien H. Turner, Tzu‐Yu Shao, Abigail E. Russi, John J. Erickson, Mandy L. Ford, Koichi Araki, Sing Sing Way · 2025 · The Journal of Immunology
43. Two Faces of NFAT Transcription Factors in Lymphocytes—A Personal Account
    Edgar Serfling · 2026 · Biomolecules
44. The tumor microenvironment in hairy cell leukemia (HCL) and splenic B cell lymphoma with prominent nucleoli (SBLPN)
    Titus Watrin, Marc Seifert, Sascha Dietrich · 2025 · Leukemia & lymphoma/Leukemia and lymphoma
45. Advances in Cancer Immunotherapy Regulators of Immune Checkpoints and Effects on the Heart
    Manaal Iqbal, Jesús Jiménez · 2026 · Current Treatment Options in Cardiovascular Medicine
46. Comprehensive Immune-Phenotyping of Peripheral Lymphocytes in Coronary Artery Disease Reveals Potential Roles of Effector Memory and PD-1⁺ CD4⁺ T Cells
    Xin Huang, Jiaxi Cheng, Leidan Zhang, Lei Jia, Chao Wu, liyuan Zheng, Fada Wang, Kefei Dou, Taisheng Li · 2026 · Inflammation
47. Myeloid derived suppressor cells potentiate virus-specific memory CD8+ T cell response
    Roman Sarkar, Mohammad Shaaz, Sharvan Sehrawat · 2023 · Microbes and Infection
48. Claudin-4 as a dual regulator of genome stability and immune evasion in high grade serous ovarian cancer
    Benjamin Guy Bitler, Julie Lang, Daniel Núñez-Avellaneda, Kian Behbakht, Natalie R. Davidson, Elizabeth R. Woodruff, Fabian R. Villagómez · 2025 · Scientific Reports
49. Polarised Transfer of Proteins Through the Syncytiotrophobalst and Tissue Culture Cell Lines
    György Berencsi, Katalin Ördög · 2012 · Springer eBooks
50. NFATc1 is Suppressed in Tumor Microenvironment of Hodgkin Lymphoma
    Krisna Murti, Neti Neti, Nyiayu Fauziah Kurniawati, Ika Kartika, Riana Sari Puspita Rasyid, Zen Hafy · 2021 · Asian Pacific Journal of Cancer Prevention
51. Mechanisms of resistance to immunotherapy
    Bernadette Blauensteiner, Theresa Lentner, Verónica Moreno‐Viedma · 2024 · Elsevier eBooks
52. Effector T Lymphocyte Migration to and Within Non-Lymphoid Tissues
    Rohit Jain, Shweta Tikoo, Gyohei Egawa, Wolfgang Weninger · 2016 · Elsevier eBooks
53. Immunity leashed - mechanisms of regulation in the human immune system
    Eirik A. Torheim · 2010 · NORA - Norwegian Open Research Archives
54. Effect of Chronic Thoracic Spinal Cord Injury (SCI) on the Peripheral Immune System in Mice
    Ji Zha · 2014
55. Mechanisms of Tim-3 Signal Transduction in the Modulation of Downstream TCR Signaling
    Judong Lee · 2013 · D-Scholarship@Pitt (University of Pittsburgh)
56. Living related donor renal transplant in human immunodeficiency virus infected patient: Case reports from tertiary care hospital in western India
    AtulK Patel, Sonal Dalal, Ketan K. Patel, Ketan D Shukla, Prakash Ishwarlal Darji · 2014 · Journal of Global Infectious Diseases
57. Évaluation de l'expression et de la valeur pronostique de PD-L1 dans les cancers colorectaux traités par chirurgie première : série rétrospective de 105 cas
    Gratiane Cogniet · 2016 · HAL
58. Immunotherapy Targeting the PD-1 Signaling Pathway
    Yoshiko Iwai · 2016 · Haigan
59. Enhancement of tolerogenic or immunostimulatory potential of dendritic cells for therapeutic goals
    Javanmard Khameneh Hanif · 2011
60. Theranostic Approaches for Pathway-Activated Systems in Oncology
    Lan V. Pham, Jerry L. Bryant, David J. Yang, Richard J Ford · 2017 · Springer eBooks
61. Immune Plasticity in Chronic Hepatitis C Virus Patients Treated With Direct-Acting Antivirals
    Jihad Aljabban · 2016 · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
62. Immunomodulation and Vaccination with RHDV VLP
    Braeden Donaldson · 2017 · Otago University Research Archive (University of Otago)
63. Análise do papel modulador da interação PD-1/PD-L1 na fase crônica da infecção murina pelo Trypanosoma cruzi.
    Raíssa Fonseca · 2018
64. TGF-BETA1/SMAD3 SUPPRESS ANTI-TUMOR IMMUNITY BY ENHANCING PD-1 EXPRESSION ON ANTIGEN-SPECIFIC CD8+ T CELLS IN CANCER
    Benjamin Vincent Park · 2015
65. Molecular cloning, expression and characterization of Pekin duck programmed death-1
    Qingxia Yao, Karl P. Fischer, D. Lorne Tyrrell, Klaus S. Gutfreund · 2019 · Gene
66. POTENSI SEL T MOBIL HER2 SPESIFIK MODIFIKASI CRISPR / CAS9 PD-1 / PD-L1 PEMBLOKIRAN SEBAGAI INOVASI TERAPI UVEAL MELANOMA
    Muhammad AH Khoiruddin, Yusi Windya Febriyanti, Nafia Amalia · 2019 · Al-Iqra Medical Journal Jurnal Berkala Ilmiah Kedokteran
67. The Divergent Role of Co-receptors and Cytokines in the Immune Response to Cancer and Self
    Christopher Tucker · 2020 · University of Minnesota Digital Conservancy (University of Minnesota)
68. Distinct dynamics and kinetics determine efficient antigen-presentation by LSEC and support IL-2 dependent CD8 T cell activation
    Anna Schurich · 2009 · bonndoc (University of Bonn)
69. Characterizing the Development of T cell Exhaustion Independent of PD-1
    Zachary Thomas Freeman · 2016
70. Immunomodulatory Effects of Human ImmunodeficiencyVirus (HIV-1) on Dendritic Cell and T cell Responses : Studies of HIV-1 effects on Dendritic cell functionality reflected in primed T cells
    Karlhans Fru · 2011
71. Regulation of the Intrahepatic CD8+ T Lymphocyte
    Joseph S. Dolina · 2013
72. Faculty Opinions recommendation of Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells.
    Laurence Crane Eisenlohr, Gabriela L. Cosma · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
73. The Regulation of Immunity
    Jeremy M. Boss · 2022 · The Journal of Immunology
74. Local Onco-Sphere: Tumor–Immune Cells Interactions
    Phei Er Saw, Erwei Song · 2023 · Springer eBooks
75. A review on mesenchymal stem cell-based therapies for autoimmune disorders
    Yashwi Sinha, Gayatri Jayendran Nair, Ajeet Kumar Srivastava, Narendra S Kumar, Lingayya Hiremath · 2023 · World Journal of Biology Pharmacy and Health Sciences
76. Virus interactions with the sphingolipid network : sphingosine kinase 2 in immunosuppression, immunopathology, and viral propagation
    Caleb J. Studstill · 2020
77. Using structural controllability in detecting effective immune system elements against cancer cells
    Ali Ebrahimi, Reihane Fayazi, Shaghayegh Baradaran Ghavami, Elahe Safari, Samane Khoshbakht, Mohadeseh Zarei Ghobadi, Mohammad Mehdi Naghizadeh, Ali Masoudi‐Nejad · 2024
78. Herpes zoster infections: epidemiology, diagnostics, and prophylaxis in light of a growing clinical problem
    Paulina Własiuk, Krzysztof Giannopoulos · 2024 · Hematology in Clinical Practice
79. Stem cell-like memory T cells are closely related to follicular helper T lymphocytes
    Nicolás Lalinde-Ruiz, David Santiago Padillo-Fino, Carlos Parra-López · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
80. Divergent Expression of PD-1 as Challenges and Chances of Immunotherapy Targeting PD-1 or PD-L1 in Cancer
    Haozhe Huang · 2024 · Lecture notes in computer science
81. The role of cellular persistence in CAR T cell therapy
    Vivien Doreen Menkhoff, Sophie Bernhard, Stefanos Michaelides, Sophia Stock, Sebastian Kobold · 2024 · Elsevier eBooks
82. Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity
    Aboli Bhingarkar, Yuyin Wang, Keito Hoshitsuki, Katherine Marie Eichinger, Sanjay Rathod, Yin Zhu, He Lyu, Andrew T. McNutt, Larry W. Moreland, Lee A. McDermott et al. · 2025 · Frontiers in Pharmacology
83. VRK2 kinase pathogenic pathways in cancer and neurological diseases
    Pedro A. Lazo · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
84. Advances in PD-1 inhibitor combination therapy for non-small cell lung cancer
    Fan Wang · 2025 · MedScien
85. Tipping the balance: the PD1-axis as a modulator in chronic inflammatory demyelinating polyneuropathy
    Melissa Sgodzai, Katharina Klöster, Hilal Karakaya, Pardis Didhevar, Lea Horstkemper, Niklas Rilke, Seray Demir, Rafael Klimas, Xiomara Pedreiturria, Alina Blusch et al. · 2025 · Brain
86. Additional file 1 of Negative prognostic behaviour of PD-L1 expression in tongue and larynx squamous cell carcinoma and its significant predictive power in combination with PD-1 expression on TILs
    Simin Ahmadvand, Norouzi, Lotf-Ali, Yousef Mohammadi, Safaei, Akbar, Bijan Khademi, Maziar Motiee‐Langroudi, Ghaderi, Abbas · 2024 · Figshare
87. Additional file 1 of A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease
    Wu, Ching-Tse, Chu, Cheng-I, Wang, Feng-Yu, Yang, Hui-Yu, Tseng, Wei-Sung, Chang, Chuang-Rung, Chang, Chien-Chung · 2022 · Figshare
88. Additional file 1 of Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancer
    Kuo, Wan-Ting, Kuo, I-Ying, Hsieh, Hung-Chia, Wu, Ssu-Ting, Wuchou Su, YiChing Wang · 2024 · Figshare
89. Immune Checkpoint Inhibitor-Induced Cardiovascular Disease: The Role of Accelerated Senescence in Vascular Dysfunction
    Bernardo Casso-Chapa, Angelica Paniagua-Bojorges, Nicolas L. Palaskas, Kevin Thomas Nead, Venkata Subrahman K Samanthapudi, Jonghae Lee, Gilbert F. Mejia, Oanh N. Hoang, Jung Hyun Kim, Steven Hsesheng Lin et al. · 2026 · Antioxidants and Redox Signaling
90. 7-Ketocholesterol promotes T cell migration through Ca2+-NFATc1 pathway-mediated F-actin polymerization and proinflammatory cytokine production in oral lichen planus
    Qin Li Jiang, Yu-Xi Tang, Gang Zhou · 2026 · Frontiers in Immunology
91. Translating IL-2/anti-IL-2 antibody complexes treatment for human tumor immunotherapy
    Pamela Caudana · 2018
92. Impact direct du VEGF-A sur le microenvironnement immunitaire en situation tumorale : modulation par les anti-angiogéniques
    Thibault Voron · 2019
93. Expression de récepteurs inhibiteurs sur les lymphocytes T infiltrant les tumeurs du rein : signification biologique et clinique
    Clémence Granier · 2018
94. The Immune Modulation Role of Low Dosage of Cyclosporin-A (LdCsA) in the Antitumor Response of the Adaptive Immune System
    Camila Flores Torres · 2019 · theses.fr (ABES)
95. Role of co-activating receptors CD226 and CD137 in T cell exhaustion
    Andrea Pichler · 2020
96. Populations lymphocytaires circulantes exprimant PD-1 au cours des cancers bronchiques avancés, valeur prédictive de réponse aux inhibiteurs de PD-1/PD-L1
    Boris Duchemann · 2021 · theses.fr (ABES)
97. Optimisation des approches de transfert adoptif de lymphocytes T dans le mélanome : édition des gènes codant pour les immune checkpoints et combinaison thérapeutique
    Lucine Marotte · 2021 · theses.fr (ABES)
98. Deciphering the mechanisms of action of anti-PD-1 monoclonal antibodies in the tumor-draining lymph node
    Mathilde Ruggiu · 2023 · theses.fr (ABES)
99. Rôle de la maturation des précurseurs protéiques par les convertases dans la réponse immunitaire anti-tumorale
    Alexia François · 2023
100. Genetic and Epigenetic Regulation of Immune Checkpoints
     Lobat Tayebi, Mohsen Abdolmaleki · 2026 · Springer eBooks